Evidence-Based Complementary and Alternative Medicine / 2013 / Article / Tab 2

Research Article

Eleutheroside E, An Active Component of Eleutherococcus senticosus, Ameliorates Insulin Resistance in Type 2 Diabetic db/db Mice

Table 2

The effect of ES and EE on the lipid profile of db/db mice.

DMESLESHEE

Total cholesterol (mg/dL)375.11 ± 74.79 238.19 ± 86.42*247.29 ± 45.91*330.59 ± 21.17
Triglyceride (mg/dL)180.24 ± 57.19 137.89 ± 35.77 113.93 ± 20.17*112.35 ± 29.75*
FFA (uEq/L)1412.78 ± 74.28 1080.16 ± 160.21*1190.08 ± 102.30 1072.38 ± 269.91*
Glucose (mg/dL)486 ± 21.53 397.8 ± 29.30*389.2 ± 21.24*315.0 ± 24.67*
Insulin (ng/mL)8 ± 1.8 2.81 ± 0.71*4.28 ± 1.29*3.56 ± 0.41*
HOMA-IR75.89 ± 13.64 36.49 ± 12.22*42.79 ± 15.95*33.5 ± 6.63*

All values are expressed as the mean ± SEM. Six-week-old db/db mice were fed experimental diet containing none, 0.05–0.01 % E. senticosus (ES) extract, and 0.1% eleutheroside E (EE) for 5 weeks.
DM: diabetes mellitus group; ESL: 0.05% ES extract supplemented group; ESH: 0.1% ES extract supplemented group; EE: 0.003% eleutheroside E supplemented group.
P < 0.05 when compared to the DM group using one-way ANOVA followed by post hoc Bonferroni’s tests.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.